National Center for Complementary & Alternative Medicine; Notice of Meeting, 23926 [06-3872]

Download as PDF 23926 Federal Register / Vol. 71, No. 79 / Tuesday, April 25, 2006 / Notices Purpose: The purpose of the meeting is to discuss services and issues related to the health of migrant and seasonal farmworkers and their families to be able to formulate recommendations to the Secretary of Health and Human Services. There will also be a site visit and public hearing regarding matters that affect the health of migrant farmworkers. Agenda: The agenda includes an overview of the Council’s general business activities. The Council will also hear presentations from experts on farmworker issues, including the status of farmworkers health at the local and national level. In addition, the Council will be going on a site visit and holding a public hearing at which migrant farmworkers, community leaders, and providers will have the opportunity to testify before the Council regarding matters that affect the health of migrant farmworkers. The site visit and hearing are scheduled for Sunday, May 21, from 2:30 p.m. to 7:30 p.m., at the Community Health Development, Inc., 200 South Evans Street, Uvalde, Texas 78801; telephone (830) 278–5604, extension 200, fax (830) 278–1836. The Council meeting is being held in conjunction with the National Farmworker Health Conference sponsored by the National Association of Community Health Centers, in San Antonio, Texas, during the same period of time. Agenda items are subject to change as priorities indicate. For Further Information Contact: Anyone requiring information regarding the Council should contact Gladys Cate, Office of Minority and Special Populations, Bureau of Primary Health Care, Health Resources and Services Administration, 5600 Fishers Lane, Maryland 20857; telephone (301) 594– 0367. Dated: April 19, 2006. Tina M. Cheatham, Director, Division of Policy Review and Coordination. [FR Doc. E6–6144 Filed 4–24–06; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES wwhite on PROD1PC65 with NOTICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory VerDate Aug<31>2005 16:59 Apr 24, 2006 Jkt 208001 Council for Complementary and Alternative Medicine (NACCAM) meeting. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. A portion of the meeting will be closed to the public in accordance with provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Complementary and Alternative Medicine. Date: June 8, 2006. Closed: 9 a.m. to 12 p.m. Agenda: Deliberation on grant applications. Open: 1 p.m. to 3:30 p.m. Agenda: Presentations on current and proposed research. Place: National Institutes of Health, 9000 Rockville Pike, Building 31C, 6th Flr., Conference Room 10, Bethesda, MD 20892. Contact Person: Martin H. Goldrosen, PhD., Executive Secretary, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892. (301) 594–2014. This public comments session is scheduled from 3–3:30 p.m. but could change depending on the actual time spent on each agenda item. Each speaker will be permitted 5 minutes for their presentation. Interested individuals and representatives or organizations are requested to notify Dr. Martin H. Goldrosen, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland, 20892, 301–594–2014, Fax: 301–480–9970. Letters of intent to present comments, along with a brief description of the organization represented, should be received no later than 5 p.m. on May 29, 2006. Anyone representative of an organization may present oral comments. Any person attending the meeting who does not request an opportunity to speak in advance of the meeting may be considered for oral presentation, if time permits, and at the discretion of the Chairperson. In addition, written comments may be submitted to Dr. Martin H. Goldrosen at the address listed above up to ten calendar days (June 18, 2006) following the meeting. PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Copies of the meeting agenda and the roster of members will be furnished upon request by contacting Dr. Martin H. Goldrosen, Executive Secretary, NACCAM, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301–594– 2014, Fax 301–480–9970, or via e-mail at naccames@mail.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance into the building by nongovernment employees. Persons without a government I.D. will need to show a photo I.D. and signin at the security desk upon entering the building. Dated: April 17, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–3872 Filed 4–24–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Basic Science. Date: June 1–2, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Dale L. Birkle, PhD, Scientific Review Administrator, Office of Scientific Review, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892. (301) 451–6570. birkled@mail.nih.gov. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Clinical Research Review. E:\FR\FM\25APN1.SGM 25APN1

Agencies

[Federal Register Volume 71, Number 79 (Tuesday, April 25, 2006)]
[Notices]
[Page 23926]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-3872]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Advisory Council for Complementary and Alternative Medicine (NACCAM) 
meeting.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 
5 U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Complementary 
and Alternative Medicine.
    Date: June 8, 2006.
    Closed: 9 a.m. to 12 p.m.
    Agenda: Deliberation on grant applications.
    Open: 1 p.m. to 3:30 p.m.
    Agenda: Presentations on current and proposed research.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31C, 6th Flr., Conference Room 10, Bethesda, MD 20892.
    Contact Person: Martin H. Goldrosen, PhD., Executive Secretary, 
National Center for Complementary and Alternative Medicine, National 
Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 
20892. (301) 594-2014.
    This public comments session is scheduled from 3-3:30 p.m. but 
could change depending on the actual time spent on each agenda item. 
Each speaker will be permitted 5 minutes for their presentation. 
Interested individuals and representatives or organizations are 
requested to notify Dr. Martin H. Goldrosen, National Center for 
Complementary and Alternative Medicine, NIH, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland, 20892, 301-594-2014, Fax: 
301-480-9970. Letters of intent to present comments, along with a 
brief description of the organization represented, should be 
received no later than 5 p.m. on May 29, 2006. Anyone representative 
of an organization may present oral comments. Any person attending 
the meeting who does not request an opportunity to speak in advance 
of the meeting may be considered for oral presentation, if time 
permits, and at the discretion of the Chairperson. In addition, 
written comments may be submitted to Dr. Martin H. Goldrosen at the 
address listed above up to ten calendar days (June 18, 2006) 
following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by contacting Dr. Martin H. Goldrosen, 
Executive Secretary, NACCAM, National Center for Complementary and 
Alternative Medicine, National Institutes of Health, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax 
301-480-9970, or via e-mail at naccames@mail.nih.gov.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by nongovernment 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.

    Dated: April 17, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-3872 Filed 4-24-06; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.